D-0868-2023 Class I Terminated

Recalled by Novis PR, LLC Dba Kramer Novis — San Juan, PR

FDA drug recall D-0868-2023 was initiated by Novis PR, LLC Dba Kramer Novis on Apr 20, 2023 and is designated Class I. Reason for recall: Product mix-up: incorrect product was found inside the G-Supress DX product carton. The recall status is terminated (terminated Sep 13, 2024). Affected quantity: 9077 bottles.

Recall details

Product Type
Drugs
Report Date
Jun 7, 2023
Initiation Date
Apr 20, 2023
Termination Date
Sep 13, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
9077 bottles

Product description

G-Supress DX (Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl) Pediatric Drops Cough Suppressant Expectorant Nasal Decongestant, Cherry Flavor Sugar & Alcohol Free, packaged in a bottle Net Content: 30 mL (1 oz.) further packaged in a carton, Manufactured in the USA for Kramer Novis, San Juan, PR 00917, NDC 52083-655-01

Reason for recall

Product mix-up: incorrect product was found inside the G-Supress DX product carton.

Distribution pattern

Puerto Rico

Code information

Lot: D20911, Exp. Oct/25

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0868-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0868-2023. Report a data issue: hello@regdatalab.com.